Nah, probably not, but I agree this news won't be well received. No free rides in these figures, Need to structure the deal with Lilly to incentivate them to market the product properly. Otherwise Axiron will not reach potential.
Q1 Result, page-4
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.44M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.4¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.00pm 10/07/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable